HROW Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Harrow Inc. (HROW) is not a strong buy for a beginner, long-term investor at this moment. While the company has shown strong revenue growth, recent earnings misses, lowered guidance, and a significant stock drop signal caution. Additionally, technical indicators suggest the stock is oversold, but there is no clear reversal signal yet. With no strong proprietary trading signals or significant positive catalysts, it is better to wait for more clarity or a stronger entry point.
The MACD is negative and expanding downward, indicating bearish momentum. RSI is at 14.463, suggesting the stock is oversold. Moving averages are converging, and the stock is trading near its S2 support level of 34.963. While the oversold RSI could hint at a potential rebound, there is no confirmation of a reversal yet.
Gross margin improved slightly to 79.27%. Plans to expand the sales force and launch new products in 2026 could drive future growth.
Q4 EPS missed estimates, and 2026 revenue guidance was lower than expected. Stock dropped 19% following the disappointing forecast. Net income and EPS declined YoY. Analysts have lowered price targets, reflecting moderated expectations.
In Q4 2025, revenue increased by 33.31% YoY to $89.09M, but net income dropped by 2.23% YoY to $6.63M. EPS declined by 5.26% YoY to $0.18. Gross margin improved slightly to 79.27%.
Analysts maintain a positive outlook with Buy and Overweight ratings, but have lowered price targets (e.g., Ladenburg to $62 from $66, Cantor Fitzgerald to $91 from $94) due to moderated revenue expectations and updated models post-Q4 report.
